Syndicate This week's upcoming IPO's and secondary offerings

Week of October 4 to October 8, 2024

This Day's Priced Deals: October 7th, 2021

Symbol

Issuer

Type

Price

Managers

LTH

Life Time Group
Life Time Group
IPO
Priced: $18.00
39M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Managers: Goldman Sachs, Morgan Stanley & BofA, Deutsche Bank, JPMorgan, Wells Fargo, BMO Capital, Mizuho, RBC Capital, Guggenheim, Oppenheimer, BTIG, TPG Capital, AmeriVet Securities, Blaylock Van, Siebert Williams

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
TCN

Tricon
Tricon
IPO
Priced: $12.40
36M
Morgan Stanley,...

Pricing after close
Deal analysis and details

Managers: Morgan Stanley, RBC Capital, Citi & Goldman Sachs

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
THRX

Theseus Pharmaceuticals
Theseus Pharmaceuticals
IPO
Priced: $16.00
10M
Jefferies,...

Pricing after close
Deal analysis and details

Managers: Jefferies, Leerink & Cantor Fitzgerald

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
OSMT

Osmotica Pharmaceuticals
Osmotica Pharmaceuticals
Spot Secondary
Priced: $2.50
14M
H.C. Wainwright

Pricing after close

Managers: H.C. Wainwright

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

This Week's Deals to be Priced

10/05 - Tuesday

Symbol

Issuer

Type

Price

Managers

IFIT

iFit Health & Fitness
iFit Health & Fitness
IPO
Postponed $18.00-21.00
30.769M
Morgan Stanley,...

Pricing after close
Deal analysis and details

Managers: Morgan Stanley, BofA, Barclays, Citi, Credit Suisse, Jefferies & Baird, DOWN, JPMorgan, Raymond James, Truist, William Blair, TSLY, AmeriVet, Blaylock, Loop Capital, Siebert Williams

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

10/07 - Thursday

Symbol

Issuer

Type

Price

Managers

AEON

AEON Biopharma
AEON Biopharma
IPO
$14.00-16.00
5M
Wells Fargo,...

Pricing after close
Deal analysis and details

Managers: Wells Fargo, Cantor Fitzgerald, Mizuho & H.C. Wainwright

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

This Week's Priced Deals

10/04 - Monday

Symbol

Issuer

Type

Price

Managers

UPH

UpHealth
UpHealth
Secondary
Priced: $1.75
23M
Oppenheimer,...

Pricing after close
Deal analysis and details

Managers: Oppenheimer, Lake Street, Northland

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

10/05 - Tuesday

Symbol

Issuer

Type

Price

Managers

EGLE

Eagle Bulk Shipping
Eagle Bulk Shipping
Block Trade
Priced: $49.50
1.1M
Morgan Stanley

Pricing after close
Deal analysis and details

Managers: Morgan Stanley

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
NVEI

Nuvei
Nuvei
IPO
Priced: $123.14
3M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Managers: Goldman Sachs, Credit Suisse, JPMorgan, BMO Capital & RBC Capital

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
VLCN

Volcon
Volcon
IPO
Priced: $5.50
3.025M
Aegis

Pricing after close
Deal analysis and details

Managers: Aegis

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
XENE

Xenon Pharmaceuticals
Xenon Pharmaceuticals
Secondary
Priced: $29.50
8.47M
Jefferies,...

Pricing after close
Deal analysis and details

Managers: Jefferies, Leerink, Stifel & RBC Capital

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
HESM

Hess Midstream Partners
Hess Midstream Partners
Spot Secondary
Priced: $26.00
7.5M
JPMorgan & Citi

Pricing after close
Deal analysis and details

Managers: JPMorgan & Citi

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
INDT

Indus Realty Trust
Indus Realty Trust
Spot Secondary
Priced: $66.00
2.15M
JPMorgan & Baird,...

Pricing after close
Deal analysis and details

Managers: JPMorgan & Baird, BTIG, BMO Capital, JMP Securities

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
MANU

Manchester United
Manchester United
Spot Secondary
Priced: $17.50
9.5M
BofA

Pricing after close

Managers: BofA

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

10/06 - Wednesday

Symbol

Issuer

Type

Price

Managers

LTH

Life Time Group
Life Time Group
IPO
Priced: $18.00
39M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Managers: Goldman Sachs, Morgan Stanley & BofA, Deutsche Bank, JPMorgan, Wells Fargo, BMO Capital, Mizuho, RBC Capital, Guggenheim, Oppenheimer, BTIG, TPG Capital, AmeriVet Securities, Blaylock Van, Siebert Williams

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
TCN

Tricon
Tricon
IPO
Priced: $12.40
36M
Morgan Stanley,...

Pricing after close
Deal analysis and details

Managers: Morgan Stanley, RBC Capital, Citi & Goldman Sachs

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
THRX

Theseus Pharmaceuticals
Theseus Pharmaceuticals
IPO
Priced: $16.00
10M
Jefferies,...

Pricing after close
Deal analysis and details

Managers: Jefferies, Leerink & Cantor Fitzgerald

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
OSMT

Osmotica Pharmaceuticals
Osmotica Pharmaceuticals
Spot Secondary
Priced: $2.50
14M
H.C. Wainwright

Pricing after close

Managers: H.C. Wainwright

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

10/07 - Thursday

Symbol

Issuer

Type

Price

Managers

CGTX

Cognition Therapeutics
Cognition Therapeutics
IPO
Priced: $12.00
3.77M
B. Riley,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: B. Riley, Oppenheimer

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ISO

IsoPlexis
IsoPlexis
IPO
Priced: $15.00
8.333M
Morgan Stanley,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Morgan Stanley, TD Cowen, Evercore ISI & Leerink

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
PYXS

Pyxis Oncology
Pyxis Oncology
IPO
Priced: $16.00
10.5M
BofA,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: BofA, Jefferies, Credit Suisse & William Blair, LifeSci Capital

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
AGRX

Agile Therapeutics
Agile Therapeutics
Spot Secondary
Priced: $.85
26.667M
Oppenheimer

Pricing after close
Deal analysis and details

Managers: Oppenheimer

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
CDTX

Cidara Therapeutics
Cidara Therapeutics
Spot Secondary
Priced: $1.55
14.84M
Cantor Fitzgerald

Pricing after close
Deal analysis and details

Managers: Cantor Fitzgerald

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

Get Full Fly Access